FDAnews
www.fdanews.com/articles/97583-immuneregen-responds-to-defense-threat-reduction-agency-request-for-information

ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information

August 23, 2007

Research and development biotechnology company ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. announced that it has recently responded to a Request for Information (RFI) from the Defense Threat Reduction Agency (DTRA) of the Department of Defense for Therapeutic Countermeasures against CDC Category A and B Threat Agents.
PR Newswire